INTRODUCTION {#h0.0}
============

*Helicobacter pylori* is a Gram-negative microaerophilic bacterium that infects about half of the world's population ([@B1][@B2][@B3]). Colonization with *H. pylori* results in both acute and chronic gastritis, and in a percentage of individuals it can lead to peptic ulcer disease or the development of stomach cancer ([@B4], [@B5]). As such, *H. pylori* has been classified by the World Health Organization as a class I carcinogen. The inflammatory response provoked by *H. pylori* includes infiltration of immune cells from both arms of the immune system into the lamina propria and gastric mucosa ([@B6], [@B7]). The inflammatory cascade is likely initiated by early interactions of *H. pylori* with the gastric epithelial cells and production of chemokines and cytokines, which elicit the recruitment of neutrophils and macrophages to the site of infection. Upon activation of an adaptive immune response, a strong T cell-mediated response culminates in the production of proinflammatory cytokines, including gamma interferon (IFN-γ) and interleukin-17 (IL-17) ([@B6], [@B8][@B9][@B18]). This cytokine network results in further recruitment of innate immunity cells to the gastric mucosa, especially neutrophils. Despite this robust immune response, *H. pylori* persists within the gastric niche to promote a chronic infection for the duration of the host's life.

In order to survive the antimicrobial peptide response imposed by the vertebrate host, many Gram-negative bacteria utilize lipid A modifications ([@B19][@B20][@B21]). Bacteria accomplish this via several strategies, including adding positively charged moieties, such as phosphoethanolamine or [l]{.smallcaps}-4-aminoarabinose to the outer leaflet, removing phosphate groups from the lipid A backbone, or changing the acylation pattern ([@B22]). Altering the bacterial surface charge reduces the binding affinity of cationic antimicrobial peptides (CAMPs) with the outer membrane. CAMPs are positively charged peptides produced by the host innate immune system that act by binding to bacteria through charged surface features, forming pores and thereby disrupting membrane integrity. For example, the enzyme responsible for dephosphorylation of the lipid A 4′-phosphate group in *H. pylori*, LpxF, is partially responsible for the resistance to the cationic antimicrobial peptide polymyxin ([@B23]). Thus, resistance to CAMPs via lipid A modification presents an important mechanism by which bacteria evade the host immune response.

An important antimicrobial factor that is also a component of the host innate immune system is calprotectin (CP). CP, a heterodimer of S100A8 and S100A9 subunits (also known as Mrp8/14, calgranulin A/B, and cystic fibrosis antigen), comprises about 50% of the neutrophil's cytoplasmic protein content and is a critical component of the host nutrient-withholding process termed nutritional immunity ([@B24], [@B25]). To prevent infection with pathogenic organisms, humans and other mammals restrict access to essential metals through nutritional immunity ([@B26]). It is clear that nutrient limitation by the host and nutrient acquisition by bacteria are crucial processes in the pathogenesis of infectious diseases. CP binds Mn and Zn with high affinity, which starves bacteria of these essential nutrient transition metals, creating a Mn- and Zn-limited environment. CP has two transition metal-binding sites: site 1 (S1; with six His) binds Mn and Zn, and site 2 (S2; with three His and three Asp) binds Zn only ([@B27], [@B28]). Previous reports have indicated that CP exhibits antimicrobial activity against numerous Gram-negative and Gram-positive pathogens ([@B27], [@B29][@B30][@B36]). Expression of CP subunits S100A8 and S100A9 increases in inflamed gastric tissues of *H. pylori*-infected individuals. Recent work has demonstrated that CP inhibits *H. pylori* growth and has the capacity to alter the activity of the major inflammatory virulence factor, the *cag* type IV secretion system ([@B37]). However, *H. pylori* persists in the gastric niche to promote chronic disease in the face of a robust immune response.

Work presented here demonstrates that *H. pylori* alters its lipid A molecules in response to CP, a phenotype that results in increased biofilm formation and increased bacterial fitness in the presence of CP. These results also demonstrate that CP-mediated nutrient restriction is responsible for the modification of lipid A, which mirrors modifications that exist in the context of LpxF inactivation, such as increased phosphate decoration of the outer membrane, increased bacterial fitness, and increased biofilm formation. Taken together, the data show that CP restricts the activity of LpxF (the 4′-phosphatase) and LpxL (an inner membrane acyltransferase) to promote resistance to CP by both inducing biofilm formation and outer membrane modification. Thus, this work indicates that *H. pylori* possesses strategies to circumvent the antimicrobial activity of CP and persist in its host.

RESULTS {#h1}
=======

*H. pylori* develops resistance to CP with exposure to subinhibitory doses. {#s1.1}
---------------------------------------------------------------------------

Transition metals are essential micronutrients required by all living organisms. In response to infection, the vertebrate host produces antimicrobial proteins, such as calprotectin, lipocalin, lactoferrin, and transferrin, which sequester soluble metal ions ([@B26], [@B31], [@B37], [@B38]). In response to this nutritional immunity, bacteria alter their physiology and deploy elegant strategies to circumvent this antimicrobial response ([@B39]). To test the hypothesis that *H. pylori* responds to and alters its cellular biology to promote bacterial resistance or tolerance to the antimicrobial activity imposed by CP, *H. pylori* was cultured *in vitro* in the presence of 100 µg/ml of CP (a subinhibitory dose for bacterial growth), and pretreated *H. pylori* cells were then subcultured in increasing concentrations of CP. The bacterial fitness of CP-pretreated *H. pylori* and nonpretreated *H. pylori* was compared. CP pretreatment significantly increased bacterial fitness compared to samples that were untreated ([Fig. 1A](#fig1){ref-type="fig"}). The addition of exogenous Zn or Mn reversed the growth defect seen in bacterial cultures that were not pretreated with CP ([Fig. 1A](#fig1){ref-type="fig"}), but it did not alter the growth of bacteria pretreated with CP ([Fig. 1A](#fig1){ref-type="fig"}). To further investigate whether the increased bacterial fitness is due to Zn chelation, a synthetic metal chelator that preferentially binds Zn, *N*,*N*,*N*′,*N*′-tetrakis(2-pyridylmethyl) ethylenediamine (TPEN), was tested for its ability to induce increased fitness in the presence of CP. *H. pylori* was grown in the presence of TPEN at concentrations below that necessary to inhibit growth (5 µM), and the ability to grow in the presence of increasing concentrations of CP was assessed. TPEN treatment of *H. pylori* led to increased resistance to CP ([Fig. 1B](#fig1){ref-type="fig"}). Together, these data indicate that exposure to CP under Zn-limiting conditions alters bacterial cell biology to confer increased resistance to the antimicrobial activity of CP. To investigate the impact of CP on metal restriction within *H. pylori*, inductively coupled plasma mass spectrometry (ICP-MS) was used. *H. pylori* was cultured with or without CP and with or without exogenous Zn or Mn supplementation. In cells grown in medium alone, Zn levels were 20-fold higher than Mn levels (average Zn level, 193 mg/kg; average Mn level, 9.33 mg/kg), demonstrating that cell-associated Mn levels are normally low within *H. pylori* in culture. The data indicated that the most profound effect of CP treatment of *H. pylori* was a 32% reduction in cell-associated Zn, a result that was statistically significant compared to cells grown in medium alone (*P* = 0.0486) ([Fig. 2](#fig2){ref-type="fig"}). Moreover, addition of exogenous Mn to CP-treated *H. pylori* increased cell-associated Zn levels. These data, combined with bacterial fitness data in the presence of CP and added transition metals, suggest that the effect of CP on *H. pylori* is largely through Zn restriction rather than Mn restriction.

![Exposure to subinhibitory levels of CP or TPEN confers increased resistance to the antimicrobial activity of CP. (A) Bacteria were cultured in medium alone (untreated) or medium plus subinhibitory concentrations of CP (CP pretreated), prior to culture in increasing concentrations of calprotectin in medium alone or medium supplemented with 100 µM Zn chloride (+ Zn) or 100 µM Mn chloride (+ Mn). (B) Bacteria were cultured in medium alone (untreated) or medium plus subinhibitory concentrations of TPEN (TPEN pretreated), prior to culture in increasing concentrations of calprotectin. Preexposure to zinc chelators (CP or TPEN) enhance bacterial fitness in the presence of increasing concentrations of CP. \*, *P* \< 0.05 via one-way ANOVA with Tukey's correction for multiple comparisons of the no-treatment group to the pretreatment with CP group. *n* = 3 biological replicates.](mbo0061525700001){#fig1}

![ICP-MS results for *H. pylori* bacteria exposed to CP. Bacteria were cultured in medium alone or medium supplemented with subinhibitory concentrations of CP, CP plus 100 µM Zn chloride, or CP plus 100 µM Mn chloride. Cell-associated levels of Zn (A) and Mn (B) (per kilogram of *H. pylori* cells) were determined by ICP-MS after *H. pylori* cells were cultured with and without CP and with and without supplementation with Zn or Mn chloride. \*, *P* \< 0.05, Student's *t* test with Welch's correction, compared to medium-alone control. *n* = 3 biological replicates.](mbo0061525700002){#fig2}

Low-Zn conditions promote biofilm formation. {#s1.2}
--------------------------------------------

During the course of investigating the growth phenotypes of *H. pylori* in response to CP, large clumps of bacterial cells and adherent bacterial cell structures on the sides of the culture tubes were observed in *H. pylori* cultures treated with subinhibitory concentrations of CP (100 µg/ml). It was hypothesized that *H. pylori* will form biofilms in response to low nutrient metal conditions imposed by CP. To investigate this, *H. pylori* was cultured with and without CP in polystyrene tubes under static conditions for 24 to 48 h. Dense, confluent, macroscopic biofilms formed at the liquid-air interface when *H. pylori* was treated with CP, as demonstrated by staining of biofilms on culture tubes with crystal violet dye ([Fig. 3A](#fig3){ref-type="fig"}). Biofilms were quantified as previously described, using a spectrophotometry-based assay ([@B40]). The ratio of biofilm to biomass was enhanced in *H. pylori* cultures treated with CP and was reversed by the addition of exogenous Zn ([Fig. 3A](#fig3){ref-type="fig"}) and partially reversed with the addition of exogenous Mn ([Fig. 3A](#fig3){ref-type="fig"}). In addition to investigating the ability of wild-type (WT) CP to induce biofilm formation in *H. pylori* cultures, the effects of previously generated mutants of CP's metal-binding sites (ΔS1 and ΔS2 single mutants and ΔS1 ΔS2 double mutant) were investigated. Treatment of *H. pylori* with the ΔS1 ΔS2 double mutant of CP resulted in no increase in biofilm formation ([Fig. 3B](#fig3){ref-type="fig"}), indicating that metal-binding activity of this protein is critical for induction of this phenotype. When *H. pylori* was cultured with metal-binding site mutants of CP harboring inactivation of either S1 (Mn/Zn-binding site) or S2 (Zn-binding site) at high concentrations (600 µg/ml), biofilm formation increased compared to that in untreated *H. pylori* ([Fig. 3C](#fig3){ref-type="fig"} and [D](#fig3){ref-type="fig"}). The observation that the ΔS1 mutant (Zn only) can still induce biofilm formation in *H. pylori* indicates that the Mn-binding activity of CP is dispensable for this phenotype. The final bacterial growth and the final biomass values from these experiments can be found in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material. To further investigate whether the biofilm phenotype is due to Zn chelation, a synthetic metal chelator that preferentially binds Zn, TPEN, was tested for its ability to induce biofilm formation. *H. pylori* was grown in the presence of TPEN at concentrations below that necessary to inhibit growth (5 µM), and the ability to form macroscopic biofilms was assessed. TPEN treatment of *H. pylori* led to increased biofilm formation, and the addition of exogenous Zn reduced biofilm formation in TPEN-treated bacteria ([Fig. 3B)](#fig3){ref-type="fig"}.

![Subinhibitory concentrations of CP induce biofilm formation and changes in cell surface hydrophobicity of *H. pylori* cultures. Evaluation of *H. pylori* biofilm formation and cell surface hydrophobicity by cells cultured in medium alone, medium supplemented with 100 µg/ml CP, medium supplemented with 100 µg/ml CP plus 100 µM Zn chloride (CP + Zn), medium supplemented with 100 µg/ml CP plus 100 µM Mn chloride (CP + Mn) (A); 600 µg/ml ΔS1 ΔS2 double mutant, 5 µM synthetic Zn chelator (TPEN), or 5 µM TPEN plus 100 µM Zn chloride (TPEN + Zn), or 5 µM TPEN plus 100 µM Mn chloride (TPEN + Mn) (B); 100 µg/ml ΔS1 mutant (ΔS1 Low), 600 µg/ml ΔS1 mutant (ΔS1 High), 600 µg/ml ΔS1 mutant plus 100 µM Zn chloride (ΔS1 High + Zn), or 600 µg/ml ΔS1 mutant plus 100 µM Mn chloride (ΔS1 High + Mn) (C); 100 µg/ml ΔS2 mutant (ΔS2 Low), 600 µg/ml ΔS2 mutant (ΔS2 High), 600 µg/ml ΔS2 mutant plus 100 µM Zn chloride (ΔS2 High + Zn), or 600 µg/ml ΔS2 mutant plus 100 µM Mn chloride (ΔS2 High + Mn) (D). The photographic images depict *H. pylori* cultures stained with crystal violet after 48 h of growth. Bar graphs on the left represent mean biofilm-to-biomass ratios (*A*~580~/*A*~600~ ± standard error of the mean). The total biofilm-to-biomass ratio was compared to that for medium alone (\*, *P* \< 0.05). The bar graphs on the right represent mean percentages of cell surface hydrophobicity (± standard errors of the means) as determined in a BATH assay. The cell surface hydrophobicity levels in the presence of CP were compared to those of cells grown in medium alone. Levels of significance were calculated based on growth via a one-way ANOVA with Tukey's correction for multiple comparisons, compared to results with medium alone. *n* = 3 to 5 biological replicates.](mbo0061525700003){#fig3}

Because alteration in biofilm formation has previously been attributed to changes in cell surface hydrophobicity ([@B41]), the hypothesis that low Zn alters the hydrophobicity of the *H. pylori* cell surface was tested using the bacterial association to hydrocarbon (BATH) assay. *H. pylori* cells cultured in the presence of CP or TPEN had decreased cell surface hydrophobicity, as indicated by a decrease in *H. pylori* cells present in the xylene fraction compared to untreated *H. pylori* or bacteria treated with TPEN and exogenous Zn ([Fig. 3A and B](#fig3){ref-type="fig"}). Live-cell imaging of biofilms by confocal laser scanning microscopy indicated that the tertiary structure of the CP-induced *H. pylori* biofilm was thicker than that of *H. pylori* grown in the absence of CP or in the presence of CP plus an exogenous source of nutrient Zn (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material).

*H. pylori* biofilms induced by Zn sequestration were also visualized by field emission gun scanning electron microscopy (FEG-SEM). The microscopic view of these biofilms indicated that *H. pylori* cultures grown in the presence of CP or TPEN adhered to polystyrene and formed larger tertiary structures than did *H. pylori* cultures grown in medium alone, medium with exogenous Zn, or medium supplemented with a Zn chelator (CP or TPEN) and exogenous Zn ([Fig. 4](#fig4){ref-type="fig"}; see also [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). These biofilms had discrete multicellular aggregates of cells that appeared to intimately adhere to each other, with channels formed between these features. *H. pylori* can be described as a Gram-negative, spiral-shaped (S-shaped) or coccus-shaped bacterium. The three forms that have been reported are the viable and culturable spiral form, the viable but nonculturable (VBNC) coccoid form, and the nonviable degenerative form. The spiral shape is believed to enhance colonization of the gastric mucosa ([@B42]), and the helical shape was recently shown to be due to a Zn-dependent carboxypeptidase ([@B43]). The electron microscopy analyses revealed that both spiral and coccoid forms of *H. pylori* are present within the CP-induced biofilms, a result that is consistent with previous analyses of *H. pylori* biofilms ([@B44]). Therefore, these data suggest that low Zn availability imposed by CP induces an *H. pylori* biofilm.

![CP-dependent metal sequestration induces *H. pylori* biofilms. SEM analyses of biofilm formation in *H. pylori* cultures grown in medium alone (A and D), medium with 100 µg/ml of CP (B and E), medium with 100 µg/ml of CP supplemented with 100 µM Zn chloride (D and F). Original magnification, ×1,000 (A to C) or ×7,000 (D to F). Bars, 40 µm (A to C) or 5 µm (D to F). Micrographs are representative of three biological replicates.](mbo0061525700004){#fig4}

Growth of *H. pylori* in the presence of CP inhibits the lipid A modification pathway. {#s1.3}
--------------------------------------------------------------------------------------

Since exposure to CP changed *H. pylori*'s surface properties and stimulated biofilm formation, we hypothesized that CP could alter the surface charge of the bacterium through modification of its lipopolysaccharide (LPS), a major surface determinant of charge ([@B45], [@B46]). To test this, lipid A purified from CP-treated *H. pylori* was evaluated by matrix-assisted laser desorption ionization--time of flight (MALDI-TOF) mass spectrometry analysis. Mass spectrometry analysis revealed two additional peaks present when *H. pylori* was treated with CP, which was unlike spectra from untreated *H. pylori* where one expected peak was evident ([Fig. 5A](#fig5){ref-type="fig"}). Adding back either Zn or Mn to *H. pylori* cultures treated with CP restored the production of wild-type lipid A, as did growth of *H. pylori* with a mutant of CP (ΔS1 ΔS2 double mutant) that does not bind Zn or Mn ([Fig. 5A](#fig5){ref-type="fig"}). Furthermore, the alteration of lipid A species was enriched in a dose-dependent manner with increasing concentrations of CP, as seen in the sample treated with 200 µg/ml CP compared to the sample treated with 100 µg/ml CP. These results indicated that Zn and/or Mn chelation by CP alters the biochemical machinery required for lipid A modification. Highlighted on the additional lipid A structures in [Fig. 5B](#fig5){ref-type="fig"} are the enzymes that could account for the structural features found on lipid A from the *H. pylori* cultures treated with CP. This result was specific to CP treatment of *H. pylori*, rather than a general stress response, because treatment of *H. pylori* with the synthetic Fe chelator 2,2′-dipyridyl did not alter the lipid A structure (data not shown) and is not involved in lipid A processing ([@B23], [@B47][@B48][@B50]). The affected pathway enzymes are an inner membrane acyltransferase, LpxL (Jhp0265), a 4′-phosphatase, LpxF (Jhp1486), and an outer membrane 3′-*O*-deacylase, LpxR (Jhp0634) ([@B23]). The predominant peak from the CP-treated *H. pylori* lipid A is at *m/z* 1546.8, consistent with the \[M-H\]^−^ ion of the wild-type structure of *H. pylori* lipid A (predicted \[M-H\]^÷^ at *m/z* 1547.1) ([Fig. 5B](#fig5){ref-type="fig"}). The additional structure observed with an *m/z* of 1825.3 is consistent with a lipid A species that is penta-acylated with a phosphate group at the 4′-position and a phosphoethanolamine residue at the 1-position. The final peak on the spectrum from the CP-treated *H. pylori* with an *m/z* of 2092.5 is consistent with a lipid A species that is hexa-acylated with a phosphate group at the 4′-position and a phosphoethanolamine residue at the 1-position (predicted \[M-H\]^−^ at *m*/*z* 2091.5). This final structure is the same lipid A species observed in an *H. pylori* Δ*lpxF* mutant, which is evidence that the lipid A modification pathway is an ordered process and the 3′-*O*-deacylase (LpxR) activity is dependent on removal of the lipid A 4′-phosphate ([@B23]). [Figure 5B](#fig5){ref-type="fig"} depicts the altered lipid A molecules revealed by mass spectrometry analyses and the corresponding enzymes that are responsible for these modifications. This discovery that metal chelation alters the lipid A structure is highly significant, because changes in the lipid A structure have only been observed in *H. pylori* harboring mutational inactivation of genes encoding enzymes for the pathway. Therefore, CP is the first host factor identified which disrupts the synthesis of lipid A in *Epsilonproteobacteria.*

![Growth of *H. pylori* in CP alters the *H. pylori* lipid A profile. Bacteria were cultured either in the absence of CP, with CP (100 µg/ml or 200 µg/ml), with CP and medium supplemented with 100 µM Mn chloride or Zn chloride, or with the double site mutant of CP (ΔS1 ΔS2 at 100 µg/ml). (A) Mass spectrometry analyses of the lipid A species in response to CP-dependent metal sequestration. (B) Depictions of lipid A molecules identified by mass spectrometry in samples derived from *H. pylori* cultures treated with CP. The enzymes associated with modifying each moiety are highlighted (LpxF \[red\], LpxR \[green\], and LpxL \[blue\]). These results are representative of three separate biological replicates.](mbo0061525700005){#fig5}

To determine whether the effect of CP on the lipid A modification pathway was a result of transcriptional control of *lpxF*, *lpxL*, and *lpxR*, transcriptional analysis of these genes was performed by real-time reverse transcription-PCR (RT-PCR). *H. pylori* was grown overnight either in medium alone, in the presence of 200 µg/ml CP, or in the presence of 200 µg/ml CP plus exogenous Zn, and transcript levels were determined using the relative gene expression method. Culture of *H. pylori* in the presence of CP did not affect transcription of *lpxF*, *lpxL*, or *lpxR* (see [Fig. S3](#figS3){ref-type="supplementary-material"} in the supplemental material), suggesting that CP regulates this pathway through a posttranscriptional mechanism.

Inactivation of the 4′-phosphatase or the inner membrane acyltransferase alters surface charge and confers resistance to CP. {#s1.4}
----------------------------------------------------------------------------------------------------------------------------

Since the MALDI-TOF profiles of lipid A molecules formed in response to CP treatment are similar to those derived from *lpxF*, *lpxL*, or *lpxR* mutants, the next hypothesis tested was that inactivation of one or more of these genes could confer increased bacterial fitness in the presence of CP. Isogenic *lpxF*, *lpxL*, and *lpxR* mutants were generated in *H. pylori*, and growth curve analyses of these strains grown in increasing concentrations of CP were performed. It was previously reported that inactivation of LpxF, LpxL, and LpxR does not affect *in vitro* growth ([@B23], [@B48]). Inactivation of LpxF or LpxL in strain G27 was sufficient to increase bacterial fitness in the presence of 500 µg/ml CP by more than 50% ([Fig. 6](#fig6){ref-type="fig"}), further supporting the hypothesis that lipid A modification can lead to resistance or tolerance to the antimicrobial activity of CP.

![LpxF inactivation leads to increased bacterial fitness in the presence of CP. Spectrophotometric analysis of bacterial growth of *H. pylori* and *H. pylori* mutants was performed after culture with increasing concentrations of CP. Strains included WT *H. pylori* strain G27 and the Δ*lpxF* isogenic derivative, Δ*lpxL* isogenic derivative, and Δ*lpxR* isogenic derivative. One-way ANOVA with Tukey's correction for multiple comparisons was performed. \*\*\*, *P* \< 0.001 for the Δ*lpxF* isogenic derivative compared to WT bacteria grown in the presence of 500 µg/ml or 1,000 µg/ml CP, or for the Δ*lpxL* isogenic derivative compared to WT in the presence of CP at 500 µg/ml. *n* = 3 biological replicates.](mbo0061525700006){#fig6}

To determine how LpxF, LpxL, or LpxR contributes to bacterial surface charge and biofilm formation, the ability of these strains to form biofilm and associate with hydrocarbons was assayed through a BATH assay in both strains G27 and 7.13. All of the isogenic mutants formed biofilms with a tertiary structure, based on macroscopic analysis and the ratio of biofilm to biomass ([Fig. 7A](#fig7){ref-type="fig"}; see also [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material).The BATH assay analyses revealed that *lpxF or lpxL* inactivation is sufficient to promote the decreased bacterial cell surface hydrophobicity that is associated with the increased biofilm phenotype observed with CP treatment (Fig. 7A; see also [Fig. S4](#figS4){ref-type="supplementary-material"}). While *H. pylori ΔlpxR* forms a modest biofilm, it does not exhibit a decreased cell surface hydrophobicity, as seen in *H. pylori ΔlpxF* and *H. pylori ΔlpxL.* This may explain why *H. pylori ΔlpxR*, which may still have some positive charges on its cell surface, is still sensitive to CP, while *H. pylori ΔlpxF* and *H. pylori ΔlpxL* exhibit increased resistance to CP. To determine if chelation of Zn by CP or TPEN could enhance the biofilm formation further in these lipid A modification mutants, WT *H. pylori* and its *lpxF*, *lpxL*, and *lpxR* mutants were cultured with subinhibitory doses of CP or TPEN. Sequestration of Zn by either mechanism did not further enhance biofilm formation or modify cell surface hydrophobicity in *H. pylori* strains with lipid A modifications ([Fig. 7B](#fig7){ref-type="fig"}; see also [Fig. S4](#figS4){ref-type="supplementary-material"}). Also, the addition of both a Zn chelator and an exogenous source of nutrient Zn or Mn did not abolish biofilm formation by the *lpxF* isogenic derivative ([Fig. 7C](#fig7){ref-type="fig"} and [D](#fig7){ref-type="fig"}; see also [Fig. S4](#figS4){ref-type="supplementary-material"}), indicating that the inactivation of *lpxF* is sufficient to induce biofilm formation regardless of Zn availability.

![Changes in lipid A modification enzymes lead to increased biofilm formation and decreased cell hydrophobicity. Macroscopic evaluation of biofilm formation was performed on static *H. pylori* cultures stained with crystal violet. Photographic images of biofilm formation of *H. pylori* strain G27 and isogenic mutants of *lpxF*, *lpxL*, and *lpxR* in the absence of CP in medium alone (A), in the presence of 100 µg/ml CP (B), in the presence of CP with medium supplemented with 100 µM Zn chloride (C), and in the presence of CP with medium supplemented with 100 µM Mn chloride (D). Quantification of the total biofilm-to-biomass ratio was calculated via a colorimetric assay and is presented in the bar graph on the left (*A*~580~/*A*~600~) ± the standard errors of the means. Cell surface hydrophobicity was determined in a BATH assay and is presented in the graphs on the right (mean percentages of cell surface hydrophobicity ± standard errors of the means). Levels of significance were calculated based on growth, using a one-way ANOVA with Tukey's correction for multiple comparisons. \*, *P* \< 0.05 compared to WT bacteria. *n* = 3 biological replicates.](mbo0061525700007){#fig7}

Microscopically, the biofilms formed by *lpxF*, *lpxL*, and *lpxR* mutants were different from those formed by treating *H. pylori* with CP. The *H. pylori* Δ*lpxF* and the *H. pylori* Δ*lpxL* mutant formed more robust biofilms than the *H. pylori* Δ*lpxR* strain ([Fig. 7](#fig7){ref-type="fig"}). While isogenic derivatives lacking expression of LpxF, LpxL, or LpxR formed biofilms with similar tertiary structures to those formed by WT *H. pylori* exposed to CP ([Fig. 4](#fig4){ref-type="fig"}), CP-induced biofilms differed from the biofilms formed by *ΔlpxF*, *ΔlpxL*, and *ΔlpxR* mutants because they exhibited increased extracellular matrix and an increased incidence of coccoid cells ([Fig. 4](#fig4){ref-type="fig"} and 8). This result was likely due to the pleiotropic effects of CP treatment, which can affect multiple cellular responses in addition to the Lpx pathway. The *ΔlpxF* mutant displayed a confluent mat of cells with a few multicellular aggregates ([Fig. 8](#fig8){ref-type="fig"}). The *ΔlpxL* and *ΔlpxR* mutants had multicellular aggregates with less-developed tertiary architectures than CP-treated cells.

![*H. pylori* cultures form biofilms with loss-of-function mutations in *lpxF*, *lpxL*, and *lpxR*. (A to C) High-resolution FEG-SEM analysis images of WT *H. pylori* strain G27 (A), WT *H. pylori* strain G27 exposed to CP (B), or *H. pylori* treated with CP plus 100 µM Zn chloride (C). (D to F) *H. pylori* Δ*lpxF* strain (D), *H. pylori* Δ*lpxL* (E), and *H. pylori* Δ*lpxR* isogenic mutants (F) grown in medium alone on plastic substrates. Original magnification, ×5,000. Bars, 5 µm. (G to I) Images of FEG-SEM analysis of *H. pylori* Δ*lpxF* (G), *H. pylori* Δ*lpxL* (H), and *H. pylori* Δ*lpxR* (I) isogenic mutant strains. Original magnification, ×1,000. Bars, 40 µm. Micrographs are representative of 3 biological replicates.](mbo0061525700008){#fig8}

DISCUSSION {#h2}
==========

In an effort to suppress microbial outgrowth, the host sequesters essential nutrients in a process termed nutritional immunity. An antimicrobial protein associated with nutritional immunity and deposited at the sites of infection by neutrophils is CP. CP has antibacterial, antifungal, and immune-modulating effects that are dependent on its transition metal-binding capacity within two independent binding sites that have been shown to bind Mn and Zn with high affinity ([@B28], [@B51]). Because CP is present at high levels during immune responses to invading pathogens when neutrophils are present, understanding the effects of transition metal binding by CP on pathogen-associated molecular patterns, biofilm formation, and bacterial fitness will have broad implications.

In addition to inhibiting *H. pylori* growth *in vitro* and modulating function of the *H. pylori* cytotoxin type IV secretion system ([@B37]), in this study, the data demonstrated that exposure to subinhibitory concentrations of CP induces increased bacterial fitness in increasing concentrations of CP, changes *H. pylori*'s outer membrane structures, and produces a mixed species of lipid A ([Fig. 5](#fig5){ref-type="fig"}), affecting hydrophobicity and biofilm formation (see the model in [Fig. 9](#fig9){ref-type="fig"}). In these studies, the dominant lipid A structure is still WT, suggesting modification of lipid A does not have to completely inactivate the *lpx* genes to see these effects. Previous work indicated that genetic inactivation of LpxF in *H. pylori* leads to the inability to colonize female C57BL/6 mice, suggesting that early establishment of infection requires LpxF ([@B23]). However, the current data suggest that partial inactivation of LpxF by Zn sequestration after the establishment of colonization and the development of inflammation may lead to increased bacterial fitness and persistence. This discovery that metal chelation alters the lipid A structure is highly significant, because changes in the lipid A structures observed here in *H. pylori* cultures under Zn-limiting conditions have only been observed in *H. pylori* cells harboring mutations that inactivate genes encoding enzymes for the pathway**.** Therefore, CP is the first host factor identified that disrupts the biosynthetic genes involved in synthesis of lipid A. Importantly, these findings suggest that additional lipid A species may be found when neutrophils are responding to infection and depositing CP at the site of inflammation. Recent studies have indicated that lipid A modification enzymes, including LpxF, are highly prevalent in many gut-associated microbes ([@B52]), suggesting that CP could have a much broader role in shaping the microbial ecology within the human body in both commensal and pathogen bacteria alike. Levels of CP, and therefore its effects on bacteria, will differ during these infections, depending on the level and type of inflammation in the area. Proinflammatory cytokines such as IL-17a and IL-22 affect CP expression by epithelial cells, and the number of neutrophils in the area greatly influences the amount of CP in the tissue. Levels of CP used for the studies reported here could indeed be physiological. Concentrations of calprotectin in tissue have been reported to be as high as 20 mg/ml in response to bacterial infections ([@B53]).

![Model of *H. pylori* lipid modification and biofilm formation as a consequence of the Zn sequestration imposed by calprotectin. Under Zn-replete conditions, *H. pylori* cytoplasmic zinc levels are high and LpxF, LpxL, and LpxR remain active, leading to wild-type lipid A production. Calprotectin, which is deposited at the site of infection by innate immune cells, decreases cytoplasmic Zn levels, resulting in decreased LpxF, LpxL, and LpxR activity. This leads to production of alternative lipid A species, enhanced biofilm formation, and increased bacterial fitness and replication in the presence of calprotectin.](mbo0061525700009){#fig9}

The data presented in this study suggest that one way *H. pylori* may survive the stress imposed by the host immune system is through outer membrane endotoxin modification and associated biofilm formation. Modifications of the lipid A molecules within the outer membrane, imposed either by nutrient metal sequestration (through treating *H. pylori* with CP) or through mutations of the Lpx machinery (especially LpxF) involved in lipid A synthesis, led to increased *H. pylori* fitness, biofilm formation, and decreased cell surface hydrophobicity *in vitro*. Interestingly, in the *H. pylori* lpxL mutant, when exogenous Zn was added back to the growth medium, there was a reduction in biofilm formation, suggesting that LpxF activity may be increased. Lipid A modifications in Gram-negative bacteria can lead to changes in biofilm formation in pathogens such as *E. coli* and *Pseudomonas aeruginosa* and the plant symbiont *Rhizobium leguminosarum* bv. *viciae* ([@B51], [@B54], [@B55]). Lipid A biosynthesis pathways have been linked to Zn availability, and several enzymes involved in these pathways are metal dependent. For example, the first committed step of lipid A biosynthesis in most Gram-negative bacteria is catalyzed by a conserved UDP-3-O-\[(*R*)-3-hydroxymyristoyl)\]-*N*-acetylglucosamine deacetylase, a Zn-dependent deacetylase also known as LpxC ([@B56][@B57][@B59]). Moreover, in *Pseudomonas aeruginosa*, activation of the response regulator ColR specifically induces phosphoehthanolamine addition to lipid A when Zn is present ([@B60]), suggesting that Zn can regulate lipid A modifications in other Gram-negative species at the transcriptional level. The data presented here demonstrate that a host protein can trigger these events in *H. pylori* through production of CP, which inhibits *H. pylori*'s lipid A modification pathway. While the crystal structure of *Salmonella enterica* serovar Typhimurium LpxR contains a Zn/Ca-binding site, it is Ca binding which supports the enzymatic activity of LpxR ([@B61], [@B62]). These observations and the data presented in this study suggest that CP inactivates these proteins by sequestering essential metals. Thus, our results indicate that CP-dependent chelation of nutrient metals leads to increased biofilm formation *in vitro* and that this is due to alterations in the lipid A modification pathway and concomitant changes in characteristics of the cell surface. This could have broad implications in other Gram-negative bacterial species for which biofilm formation is a key virulence determinant.

Within chronic bacterial infections, the invading prokaryotes often persist in tissues in a biofilm state ([@B63]). A biofilm is a single- or multispecies community of organisms, typically attached to an abiotic or biotic surface in an architectural structure of cells that exist in a self-secreted matrix. This matrix is comprised of hydrated polysaccharides, secreted proteins, glycopeptides, extracellular DNA, and lipids ([@B64]). The presence of biofilm-associated extracellular matrix is well established in the literature for diverse bacterial pathogens such as *Staphylococcus epidermidis*, *Vibrio cholerae*, *Yersinia pestis*, *P. aeruginosa*, and *Listeria monocytogenes* among others ([@B65][@B66][@B68]). *H. pylori* biofilm extracellular matrices have been shown to contain proteomannans, extracellular DNA, and outer membrane vesicles ([@B69][@B70][@B71]). CP- or TPEN-induced biofilms differ from the biofilms formed by *ΔlpxF*, *ΔlpxL*, and *ΔlpxR* mutants because CP-induced biofilms exhibit increased extracellular matrix compared to Lpx pathway mutants. This result is likely due to the pleiotropic effects of CP or TPEN treatment, which could affect multiple cellular responses in addition to the Lpx pathway. On the other hand, the available data do not allow us to rule out that biofilm formation and cell surface hydrophobicity are secondary effects.

Biofilms are characterized by increased resistance to antibiotics and antimicrobials (up to 1,000-fold) due to the physiological properties of the community structure ([@B63], [@B72]). Frequently, exposure to antimicrobial molecules induces biofilm formation in a variety of pathogens, including *Staphylococcus aureus*, *Streptococcus mutans*, and *P. aeruginosa* ([@B73][@B74][@B75]). Interestingly, a correlation exists between increased calprotectin expression and concomitant increases in biofilm formation with the dental pathogen *S. mutans* ([@B76]). Similarly, exposure to subinhibitory concentrations of amoxicillin and clarithromycin can increase *H. pylori* biofilm formation ([@B77]). While *H. pylori* biofilms have been previously observed via scanning electron microscopy, here we found that a host protein can induce this tertiary biofilm structure and that the structure correlates with changes in the lipid A biosynthesis pathway. CP-induced biofilm formation may protect *H. pylori* from a constantly changing environment within the host or in the environment,making these structures important for pathophysiology as well as resistance to both antimicrobial therapeutics and clearance by the immune system ([@B44]).

Our results combined with previously published work ([@B37]) reveal that *H. pylori* responds to the presence of CP (or TPEN) by altering its repertoire of toxins. Zn sequestration modulates the function of the *cag*-T4SS pili responsible for secreting the cytotoxin CagA ([@B37]) and the endotoxin-associated lipid A modification pathway, cell surface hydrophobicity, and bacterial fitness. Such changes in bacterial cell biology may augment bacterial survival during exposure to inflammation-associated antimicrobials. These insights suggest a potential target and a new strategy for antimicrobial therapies of the future.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains, CP purification, and culturing. {#s3.1}
--------------------------------------------------

*H. pylori* strains G27 and 7.13 (B128 derivative) were used for these studies. *H. pylori* strains were cultured on tryptic soy agar plates supplemented with 5% sheep blood or in brucella broth supplemented with 10% fetal bovine serum (FBS) at 37°C in room air supplemented with 5% CO~2~. Purification of calprotectin was performed, as previously described ([@B28]). *H. pylori* strains G27 and 7.13 with mutations in *lpxF*, *lpxL*, or *lpxR* were generated using constructs provided by the Trent laboratory, as previously described ([@B23], [@B48]).

Growth curve analyses. {#s3.2}
----------------------

For bacterial growth assays, *H. pylori* strains were grown under shaking conditions in 60% brucella broth plus 40% calprotectin buffer ([@B28]) supplemented with 10% FBS alone or supplemented with 100 µM Zn chloride and/or 100 µM Mn chloride, with increasing concentrations of CP at 37°C in room air supplemented with 5% CO~2~. Bacterial growth was measured using a spectrophotometric reading (optical density) at 600 nm (OD~600~). Pretreatment assays were performed by exposing *H. pylori* to subinhibitory concentrations of CP (100 µg/ml) for 24 h prior to 1:10 dilution subculture and exposure to increasing concentrations of CP alone or in the presence of an exogenous nutrient metal source (Zn/Mn).

Inductively coupled plasma mass spectrometry. {#s3.3}
---------------------------------------------

Bacterial cells were grown in 60% brucella broth plus 40% calprotectin buffer ([@B28]) supplemented with 10% FBS alone or with 200 µg/ml CP, or CP plus 100 µM exogenous metal (zinc chloride or manganese chloride) for 24 h, with shaking, at 37°C in room air supplemented with 5% CO~2~. Cells were pelleted at 4,000 × *g* for 15 min before washing once with 0.5 M EDTA and three times with 5 ml of distilled water. Samples were weighed and digested in 1 ml of 50% nitric acid overnight at 50°C. Elemental quantification was performed using a Thermo-Element 2 HR-ICPMS apparatus (Thermo, Fisher Scientific, Bremen, Germany), as previously described ([@B30]).

Biofilm assays. {#s3.4}
---------------

*H. pylori* biofilms were grown in 3-ml polystyrene tubes (under static conditions) in 60% brucella broth plus 40% calprotectin buffer ([@B28]) supplemented with 10% FBS alone or with 200 µg/ml CP, or CP plus 100 µM exogenous metal for 2 to 4 days at 37°C in room air supplemented with 5% CO~2~. After biofilms were formed, they were quantitatively analyzed, as previously described ([@B40]), by measuring the OD~600~, staining the biofilm with crystal violet, and resolubilizing the crystal violet in 80% ethanol--20% acetone solution before measuring the absorbance (OD) at 540 nm. The ratio of total biofilm to biomass was calculated via the formula OD~540~/OD~600~.

BATH assay. {#s3.5}
-----------

Cell surface hydrophobicity can be determined via a BATH assay, which measures the percentage of bacterial cells that are associated with the xylene fraction as a measure of hydrophobicity. The *H. pylori* biofilm was scraped and resuspended in 1.2 ml PUM buffer (phosphate, urea, and magnesium sulfate; 0.1 M K~2~HPO~4~ ⋅ 3H~2~O, 50 mM KH~2~PO~4~, 30 mM urea, 0.5 M MgSO~4~ ⋅ 7H~2~O; pH 7.10), and the bacterial density was obtained by measuring the absorbance (OD) at 540 nm. Two hundred microliters of xylene was then added, and the sample was vortexed vigorously and allowed to separate into aqueous and hydrocarbon fractions. The aqueous fraction was carefully pipetted out, and the bacterial density was measured spectrophotometrically. The percent cell surface hydrophobicity was determined using the following equation: {\[(*A*~540~ before xylene addition) − (*A*~540~ after xylene addition)\]/(*A*~540~ before xylene addition)} × 100, as previously described ([@B41]).

Field emission gun scanning electron microscopy of biofilms. {#s3.6}
------------------------------------------------------------

*H. pylori* biofilms were imaged by FEG-SEM analysis using methods previously described ([@B40]). Briefly, *H. pylori* biofilms were grown on polystyrene for 48 h at 37°C in the presence of 5% CO~2~. Cells were fixed with 2.0% paraformaldehyde--2.5% glutaraldehyde in 0.05 M sodium cacodylic acid buffer for 1 h at room temperature. Samples were washed three times with cacodylic acid buffer before sequential dehydration with increasing concentrations of ethanol. Samples were then dried at the critical point, mounted onto SEM stubs, painted with colloidal silver at the sample edge, and sputter coated with 20-nm-diameter gold-palladium. Samples were visualized with an FEI Quanta 250 FEG-SEM apparatus under high vacuum pressure, and micrographs were analyzed with ImageJ software.

Confocal laser scanning microscopy. {#s3.7}
-----------------------------------

*H. pylori* biofilms were grown on plastic coverslips as described above, washed three times with 1× phosphate-buffered saline (PBS) and placed in 1 ml PBS before staining with the Live/Dead BacLight kit (Life Technologies), which is comprised of SYTO 9 (green) and propidium iodide (red) and entails counterstaining with calcofluor white (blue; Sigma Aldrich). Biofilms were stained with 6 µl of 1.67 mM SYTO 9 and 1.67 mM propidium iodide mixture, and counterstained with 6 µl of 10-mg/ml calcofluor white solution for 1 h; the biofilms were washed three times with 1× PBS and mounted onto coverslips with ProLong gold antifade reagent (Life Technologies). Samples were imaged with a Zeiss 710 confocal laser scanning microscope and analyzed using Zen software.

Purification and analysis of lipid A. {#s3.8}
-------------------------------------

*H. pylori* lipid A extraction was carried out by mild acid hydrolysis as previously described ([@B23], [@B78]). For mass spectrometry, lipid A was analyzed using a MALDI-TOF/TOF (ABI 4700 Proteomics analyzer) mass spectrometer in the negative mode, as previously described ([@B23], [@B78]).

RNA isolation and analysis of gene expression by real-time PCR. {#s3.9}
---------------------------------------------------------------

Total RNA was isolated from *H. pylori* using by using Tri reagent solution (Ambion) according to the manufacturer's instructions, with slight modifications. Bacterial pellets were resuspended in Tri reagent solution, and one chloroform extraction was performed. The RNA was then mixed with 70% ethanol and purified using the RNeasy minikit (Qiagen). RNA samples were DNase treated using DNA-free DNase (Ambion). RNA was then reverse transcribed using the high-capacity RNA-to-cDNA kit (Applied Biosystems). As a control, samples were processed without reverse transcriptase. The cDNA and control reaction mixtures were diluted 1:10 and used in real-time PCRs. Real-time PCR was performed using a Step one Plus real-time PCR machine (Applied Biosystems), with SYBR green as the fluorochrome. Abundance of transcript was calculated using the ΔΔ*CT* method, with each transcript signal normalized to the abundance of the 16S rRNA internal control. The normalized transcript signal for each sample was then compared to similarly normalized values obtained with bacteria grown *in vitro* or under control conditions. Primer sequences were as follows: *lpxl* forward, 5′ TATGAGTAGGCGAGAGGCGT 3′; *lpxl* reverse, 5′ GTAGCGGCGCGATAAAATAG 3′; *lpxf* forward, 5′ CCCTACGGCTTGCAAAATAA 3′; *lpxf* reverse, 5′ GGGCTTGGGATCTTTCTTTC 3′; *lpxr* forward, 5′ TTGCATGACAACCACCCTTA 3′; *lpxr* reverse, 5′ GCGTGTTCCAGCCATAAAAT 3′.

Statistical analysis. {#s3.10}
---------------------

Statistical analyses of bacterial growth, BATH assay results, polymyxin MICs, and quantitative biofilm assays were performed using one-way analysis of variance (ANOVA) with Tukey's correction for multiple comparisons, or a paired two-tailed Student's *t* test. All data were derived from at least three separate biological replicates unless specified otherwise. Statistical analyses were performed using GraphPad Prism software.

SUPPLEMENTAL MATERIAL {#sm1}
=====================

###### 

Live-cell imaging of biofilms by confocal laser scanning microscopy. Bacterial biofilms grown on plastic coverslips were stained with SYTO 9 (green) and propidium iodide (red) and counterstained with Calcofluor white (blue). (A) *H. pylori*; (B) *H. pylori* cultured with subinhibitory doses of CP; (C) *H. pylori* cultured with subinhibitory doses of CP and supplemented with Zn chloride. Images are representative of 3 to 4 biological replicates. Download
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Figure S1, PDF file, 0.1 MB
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Bacteria exposed to TPEN exhibit biofilm formation complete with tertiary architecture and matrix formation between cells. The SEM images show biofilm formation in *H. pylori* cultures grown in medium alone (A), medium with TPEN (B), or medium with TPEN supplemented with 100 µM zinc chloride (C). Bacteria grown in medium alone formed scattered microcolonies on hydrophobic plastic substrates. This result was reversed by the addition of an exogenous zinc source. Original magnification, ×7,000. Bars, 10 µm. Images are representative of 3 biological replicates. Download
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Figure S2, PDF file, 0.2 MB
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CP has no effect on transcription of *lpxF*, *lpxL*, or *lpxR.* (A) Real-time RT-PCR analysis of transcript levels of *lpxF*, *lpxL*, or *lpxR* after overnight coculture with CP (200 µg/ml) or CP + Zn. Download
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Figure S3, PDF file, 0.03 MB
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Changes in lipid A modification enzymes leads to increased biofilm formation and decreased cell hydrophobicity. Macroscopic evaluation of *H. pylori* strain 7.13 biofilm formation in WT strain 7.13 and isogenic mutants of *lpxF and lpxR* in the presence of medium alone (A), in the presence of CP (B), in the presence of CP supplemented with 100 µM zinc chloride (C), in the presence of TPEN (D), or in the presence of TPEN with medium supplemented with 100 µM zinc chloride (E). The macroscopic images depict static cultures stained with crystal violet. Quantification of the total biofilm-to-biomass ratio was determined in a colorimetric assay. Cell surface hydrophobicity was determined in a BATH assay, which measures the percentage of bacterial cells associated with the xylene fraction as a measure of hydrophobicity. \*, *P* \< 0.05, one-way ANOVA with Tukey's correction for multiple comparisons. *n* = 3 biological replicates. Download
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Figure S4, PDF file, 0.3 MB
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Growth (OD~600~) and biomass concentrations (in micrograms of protein per milliliter) after static culture of *H. pylori* under different culture conditions for 24 h.
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Table S1, PDF file, 0.3 MB
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